Stock Drop Suit Against Drug Maker Dismissed For Lack Of Actionable Misstatement
NEW YORK — A federal judge in New York on March 28 ruled that the lead plaintiff in a securities class action lawsuit against a pharmaceutical company and two of its...To view the full article, register now.
Already a subscriber? Click here to view full article